Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K3OY
|
||||
| Drug Name |
Dovitinib
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Endometrium Cancer [ICD10:C54.1] | Phase 2 | [1] | ||
| Formula |
C21H21FN6O
|
||||
| PubChem Compound ID | |||||
| Drug Resistance Mutation (DRM) | |||||
| DRM | DRM Info | ||||
| References | |||||
| REF 1 | Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.